Senator Rick Scott, chairman of the U.S. Senate Special Committee on Aging, led a hearing titled “Made in America: Restoring Trust in Our Essential Medicines.” The session focused on American companies that are producing essential generic medicines domestically and highlighted the role of U.S. manufacturing in ensuring drug safety, creating jobs, and strengthening national security.
During the hearing, witnesses discussed ongoing challenges faced by American manufacturers as they work to rebuild the nation’s pharmaceutical base. These challenges include regulatory hurdles, aggressive foreign price manipulation, and heavy reliance on supply chains connected to China. Committee members addressed these obstacles and outlined steps forward, stressing the need to boost innovation within the United States, establish a level playing field for domestic producers, and accelerate efforts to reduce dependence on foreign-made generic drugs.
The hearing is part of bipartisan work led by Chairman Scott to secure America’s drug supply. Initiatives by Chairman Scott and Ranking Member Kirsten Gillibrand have included sending letters to major U.S. pharmacies, FDA Commissioner Martin Makary, Secretary of Health and Human Services Robert F. Kennedy Jr., executives from pharmaceutical distributors, and group purchasing organizations. They also released an investigative report highlighting the country’s significant reliance on foreign-manufactured generics. Previous committee hearings held on September 17 and October 8 similarly examined threats posed by this dependence and explored solutions for expanding domestic manufacturing while ensuring Americans have access to safe, high-quality medicines.
“See Chairman Scott’s full remarks HERE or by clicking the image above.”
